JENBURKT PHARMACEUTICALS
Back to Cashflow Statement
|
JENBURKT PHARMACEUTICALS Last 5 Year Net Cash Inflow / Outflow History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Cash Inflow / Outflow | ₹0.47 Cr | ₹-1.37 Cr | ₹2.54 Cr | ₹-0.04 Cr | ₹1.31 Cr |
What is the latest Net Cash Inflow / Outflow ratio of JENBURKT PHARMACEUTICALS ?
Year | Net Cash Inflow / Outflow |
---|---|
Mar2024 | ₹0.47 Cr |
Mar2023 | ₹-1.37 Cr |
Mar2022 | ₹2.54 Cr |
Mar2021 | ₹-0.04 Cr |
Mar2020 | ₹1.31 Cr |
How is Net Cash Inflow / Outflow of JENBURKT PHARMACEUTICALS Trending?
Years | Net Cash Inflow / Outflow | % Change | |
---|---|---|---|
Mar2024 | ₹0.47 Cr | Positive | |
Mar2023 | ₹-1.37 Cr | Negative | |
Mar2022 | ₹2.54 Cr | Positive | |
Mar2021 | ₹-0.04 Cr | Negative | |
Mar2020 | ₹1.31 Cr | - |
Compare Net Cash Inflow / Outflow of peers of JENBURKT PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
JENBURKT PHARMACEUTICALS | ₹495.9 Cr | -7.6% | -7.6% | 31.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹418,744.0 Cr | -4.2% | -7.7% | 24.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹152,209.0 Cr | -0.6% | -5.6% | 57.5% | Stock Analytics | |
CIPLA | ₹117,762.0 Cr | 3.3% | -4.8% | 6.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,705.3 Cr | -2.4% | -12.8% | 1.1% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,929.3 Cr | -0.3% | -2.1% | 24.5% | Stock Analytics |
JENBURKT PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
JENBURKT PHARMACEUTICALS | -7.6% |
-7.6% |
31.1% |
SENSEX | 0.3% |
-1.8% |
8.6% |
You may also like the below Video Courses